Showing results (221-230 of 714) with videos related to
Sort By:
Pageof 72
Veterinary Microbiology|July 13, 2013
Analysis of prion protein aggregates in blood and brain from pre-clinical and clinical BSE casesO Bannach, E Reinartz, F Henke, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 6, 2009
Effects of denosumab in patients with bone metastases with and without previous bisphosphonate exposureJean-Jacques Body, Allan Lipton, Julie Gralow, et al.Clinical and Experimental Immunology|August 22, 2003
Donor dependent, interferon-gamma induced HLA-DR expression on human neutrophils in vivoW Reinisch, C Lichtenberger, G Steger, et al.Molecular Carcinogenesis|June 1, 2007
Progressive up-regulation of genes encoding DNA methyltransferases in the colorectal adenoma-carcinoma sequenceWolfgang M Schmidt, Roland Sedivy, Birgit Forstner, et al.Nucleic Acids Research|July 25, 2000
Molecular characterization at the RNA and gene levels of U3 snoRNA from a unicellular green alga, Chlamydomonas reinhardtiiM Antal, A Mougin, M Kis, et al.European Journal of Gastroenterology & Hepatology|March 31, 2000
Benefit of interferon-alpha2b in a patient with unresectable hepatoma and chronic infection with hepatitis C virusG J Locker, R M Mader, B Steiner, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2010
Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapyM Aapro, A Fabi, F Nolè, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1987
Possible adverse effect of failed adjuvant chemotherapy on the prognosis of women receiving consecutive chemotherapy for recurrent breast cancerC Dittrich, R Jakesz, K Pirich, et al.Wiener Klinische Wochenschrift|December 10, 1999
[Clinical phase II-evaluation of neoadjuvant, cytostatic combination chemotherapy with docetaxel and epidoxorubicin in female breast cancer patients (T1-4, N0-2, M0)]C Wenzel, M Schmidinger, G J Locker, et al.Zentralblatt Fur Chirurgie|March 4, 1999
[Neoadjuvant chemotherapy of patients with breast carcinoma]R Jakesz, S Taucher, M Gnant, et al.Pageof 72